PROJECT NAME: MOLNUPIRAVIR | |||||
---|---|---|---|---|---|
Sr. No. | Abbreviation | Name | Structure | Quantity | Cost |
1. | Impurity A
CAS No: |
1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-4-(hydroxyamino)pyrimidin-2-one
C9H15N3O7 |
|||
2. |
CAS No: |
2-Propanone, O-(2-methyl-1-oxopropyl) Oxime
C7H13NO2 |
|||
3. |
CAS No: |
4-amino-1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one
C9H13N3O5 |
|||
4. | Impurity B
CAS No: |
((3aR,4R,6R,6aR)-6-(4-(Hydroxyimino)-2-oxo-3,4-dihydropyrimidin-1(2H)-yl)-2,2-dimethyltetrahydrofuro[3,4-d][1,3]dioxol-4-yl)methyl Isobutyrate
C16H23N3O7 |
|||
5. |
CAS No: |
((3aR,4R,6R,6aR)-6-(4-Amino-2-oxopyrimidin-1(2H)-yl)-2,2-dimethyltetrahydrofuro[3,4-d][1,3]dioxol-4-yl)methyl Isobutyrate
C16H23N3O6 |
|||
6. |
CAS No: |
4-amino-1-((3aR,4R,6R,6aR)-6-(hydroxymethyl)-2,2-dimethyltetrahydrofuro[3,4-d][1,3]dioxol-4-yl)pyrimidin-2(1H)-one sulfate
C12H19N3O9S |
|||
7. |
CAS No: |
Diacylated Impurity
C17H25N3O8 |
|||
8. |
CAS No: |
1-[(2R,3R,4S,5R)-3,4-Dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4(1H,3H)-dione
C9H12N2O6 |
|||
9. |
CAS No: |
Uridine Acylation
C13H18N2O7 |
PROJECT NAME: LINAGLIPTIN | |||||
---|---|---|---|---|---|
Sr. No. | Abbreviation | Name | Structure | Quantity | Cost |
1. | Impurity A
CAS No: |
3-methyl-Bis-3,7(2-butyn-1-yl)-8-[3-amino-piperidin-1-yl]-xanthine
C19H24N6O2 |
|||
2. | Impurity B
CAS No: |
8-bromo-3-methyl-3,7-dihydro-1H-purine-2,6-dione
C6H5BrN4O2 |
|||
3. | Impurity C
CAS No: |
8-[(3R)-3-aminopiperidin-1-yl]-7-(but-2-yn-1-yl)-3-methyl-3,7-dihydro-1H-purine-2,6-dione
C15H20N6O2 |
|||
4. | Impurity D
CAS No: |
8-bromo-7-(but-2-yn-1-yl)-3-methyl-3,7-dihydro-1H-purine- 2,6-dione
C10H9BrN4O2 |
|||
5. | Impurity E (Stage-II)
CAS No: |
8-bromo-7-(but-2-yn-1-yl)-3-methyl-1-(naphthalen-2-ylmethyl)-3,7-dihydro-1H-purine-2,6-dione
C20H17BrN6O2 |
|||
6. | Impurity F
CAS No: |
(3R)-1-[(4-methylquinazolin-2-yl) methyl]iperidine-3-amine
C15H20N4 |
|||
7. | Impurity G | 1-[(4-methyl-quinazolin-2yl)methyl]-3-methyl-7-(2-butyn-1-yl)-8-[-3-hydroxypiperidin-1-yl]-xanthine
C25H27N7O3 |
|||
8. | Impurity H (Stage-III)
CAS No: |
1-[(4-methyl-quinazolin-2yl)methyl]-3-methyl-7-(2-butyn-1-yl)-8-[(R)-3-(tert.-butyoxy carbonylamino)-piperidin-1-yl]-xanthine
C30H36N8O4 |
|||
9. | Impurity I
CAS No: |
1-[(4-methyl-quinazolin-2yl)methyl]-3-methyl-7-(2-butyn-1-yl)-8-[(S)-3-amino-piperidin-1-yl]-xanthine
C25H28N8O2 |
10. | ImpurityJ
CAS No: |
2-(Chloromethyl)-4-methylquinazoline
C10H9ClN2 |